The Resilience of Early-stage European Healthtech
Total funding for Pre-seed to Series B European healthtech companies grew 49% YoY from 2020 to 2021 and remained resilient in 2022 with an 8% YoY growth, reaching $4.4 billion.
Regulator · GE · 1 documents
Total funding for Pre-seed to Series B European healthtech companies grew 49% YoY from 2020 to 2021 and remained resilient in 2022 with an 8% YoY growth, reaching $4.4 billion.